Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2010-7-30
pubmed:abstractText
Replacing heparin with bivalirudin has been beneficial in patients undergoing coronary intervention and coronary artery bypass. The use of this alternative anticoagulant during peripheral bypass operations has not been studied. Concerns over distal thrombosis using this direct thrombin inhibitor (DTI) prompted a single-arm, open-label, pilot prospective trial of bivalirudin in patients undergoing lower extremity bypass to assess perioperative safety and efficacy.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1097-6809
pubmed:author
pubmed:copyrightInfo
Copyright (c) 2010 Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved.
pubmed:issnType
Electronic
pubmed:volume
52
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
369-74
pubmed:meshHeading
pubmed-meshheading:20478686-Aged, pubmed-meshheading:20478686-Ankle Brachial Index, pubmed-meshheading:20478686-Anticoagulants, pubmed-meshheading:20478686-Arterial Occlusive Diseases, pubmed-meshheading:20478686-Blood Loss, Surgical, pubmed-meshheading:20478686-Hemorrhage, pubmed-meshheading:20478686-Hirudins, pubmed-meshheading:20478686-Humans, pubmed-meshheading:20478686-Infusions, Intravenous, pubmed-meshheading:20478686-Lower Extremity, pubmed-meshheading:20478686-Ohio, pubmed-meshheading:20478686-Peptide Fragments, pubmed-meshheading:20478686-Pilot Projects, pubmed-meshheading:20478686-Prospective Studies, pubmed-meshheading:20478686-Recombinant Proteins, pubmed-meshheading:20478686-Reoperation, pubmed-meshheading:20478686-Saphenous Vein, pubmed-meshheading:20478686-Thrombin, pubmed-meshheading:20478686-Thrombosis, pubmed-meshheading:20478686-Time Factors, pubmed-meshheading:20478686-Treatment Outcome, pubmed-meshheading:20478686-Vascular Patency, pubmed-meshheading:20478686-Vascular Surgical Procedures
pubmed:year
2010
pubmed:articleTitle
A pilot, prospective evaluation of a direct thrombin inhibitor, bivalirudin (Angiomax), in patients undergoing lower extremity bypass.
pubmed:affiliation
Department of Vascular Surgery, Cleveland Clinic, Cleveland, Ohio 44195, USA. kashyav@ccf.org
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Clinical Trial, Phase III